Medicare Coverage of Novo Nordisk's Wegovy Could Cost up to $145B Annually
Danaher Analyst Ratings
FDA Approves Illumina's TruSight Oncology Biomarker Test
Dow Hits Closing High as Market Holds On to Records | Wall Street Today
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
Walgreens, Hims Stocks Drop as Lilly Rolls Out Cheap Weight-loss Drugs
Sanders To Press Eli Lilly On Cutting Costs For Weight Loss Drugs
Addex Stock Rallies 45% on Indivior Collaboration Update
Dow Cautious at All-Time High, Market Holding Its Breath
Why Hims & Hers Health Stock Is Falling
Lilly Shares Are Trading Higher After the Company Announced the Release of Zepbound Single-dose Vials at Reduced Prices.
Eli Lilly Analyst Ratings
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods
Exchange-Traded Funds Edge Lower, Equity Futures Mixed Pre-Bell Tuesday as Stocks Struggle for Direction
Today's Morning Movers and Top Ratings | NVDA, CAVA, AAPL, LLY and More
Eli Lilly Zepbound Prices Slashed by 50% for Lowest Doses
Ready for Fed Rate Cuts? Biotech's Potential to Watch
US Morning News Call | Stock Futures Were Flat as Traders Wager on Big Move After Nvidia Earnings
Pfizer Launches Direct Sales Website for Common Vaccines, Medicines